Immune surveillance for vaccine-preventable diseases

References

• Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006 May 27;367(9524):1747–1757.
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012 Dec 15;380(9859):2095–2128.
   PubMed Web of Science ®Google Scholar
• Racaniello VR. Emerging infectious diseases. J Clin Invest. 2004 Mar 15;113(6):796–798.
   PubMed Web of Science ®Google Scholar
• Jones KE, Patel NG, Levy MA, et al. Global trends in emerging infectious diseases. Nature. 2008 Feb 21;451(7181):990. online.
   PubMed Web of Science ®Google Scholar
• Heymann DL, Rodier GR. Hot spots in a wired world: WHO surveillance of emerging and re-emerging infectious diseases. Lancet Infect Dis. 2001 Dec 01;1(5):345–353.
   PubMedGoogle Scholar
• Plotkin SA, Plotkin SA. Correlates of vaccine-induced immunity. Clinl Infect Dis. 2008;47(3):401–409.
   PubMed Web of Science ®Google Scholar
• Plotkin SA, Gilbert PB. Nomenclature for immune correlates of protection after vaccination. Clinl Infect Dis. 2012;54(11):1615–1617.
   PubMed Web of Science ®Google Scholar
• Panda A, Qian F, Mohanty S, et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol. 2010 Mar 1;184(5):2518–2527.
   PubMedGoogle Scholar
• Zimmerman RK, Lauderdale DS, Tan SM, et al. Prevalence of high-risk indications for influenza vaccine varies by age, race, and income. Vaccine. 2010 Sep 07;28(39):6470–6477.
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Zhou X, Talbot HK, et al. The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine. 2012;30(12):2060–2067.
   PubMed Web of Science ®Google Scholar
• Harder T, Takla A, Rehfuess E, et al. Evidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal tools [journal article]. BMC Med Res Methodol. 2014 May 21;14(1):69.
   PubMedGoogle Scholar
• Evidence-based methodologies for public health [Technical report]. ECDC; 2011.
   Google Scholar
• Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005;6(5):271–278.
   PubMed Web of Science ®Google Scholar
• Govaert TM, Thijs C, Masurel N, et al. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. Jama. 1994;272(21):1661–1665.
   PubMed Web of Science ®Google Scholar
• Katzelnick LC, Montoya M, Gresh L, et al. Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort. Proc Nat Acad Sci. 2016;113(3):728–733.
   PubMed Web of Science ®Google Scholar
• Verstraeten T, Jumaan AO, Mullooly JP, et al. A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination. Pediatrics. 2003;112(2):e98–e103.
   PubMed Web of Science ®Google Scholar
• Isacson J, Trollfors B, Taranger J, et al. Safety, immunogenicity and an open, retrospective study of efficacy of a monocomponent pertussis toxoid vaccine in infants. Pediatr Infect Dis J. 1994;13(1):22–27.
   PubMed Web of Science ®Google Scholar
• Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;19(3):187–195.
   PubMed Web of Science ®Google Scholar
• Brunell PA, Gershon AA, Uduman SA, et al. Varicella-zoster immunoglobulins during varicella, latency, and zoster. J Infect Dis. 1975;132(1):49–54.
   PubMed Web of Science ®Google Scholar
• Aftandelians R, Connor JD. Bactericidal antibody in serum during infection with Bordetella pertussis. J Infect Dis. 1973;128(4):555–558.
   PubMed Web of Science ®Google Scholar
• van Gageldonk PGM, van Schaijk FG, van der Klis FR, et al. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J Immunol Methods. 2008 Jun 01;335(1):79–89.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Correlates of vaccine-induced protection: methods and implications. Geneva, Switzerland: World Health Organization; 2013.
   Google Scholar
• Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccin Immunol. 2010;17(7):1055–1065.
   PubMed Web of Science ®Google Scholar
• Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design [Review article]. Nat Rev Immunol. 2008 Apr 01;8(4):247. online.
   PubMed Web of Science ®Google Scholar
• Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: reevaluation of protective titers. J Infect Dis. 1990;162(5):1036–1042.
   PubMed Web of Science ®Google Scholar
• Gouma S, Schurink-van’t Klooster TM, de Melker HE, et al., Mumps serum antibody levels before and after an outbreak to assess infection and immunity in vaccinated students. Open Forum Infect Dis. 2014;1(3):ofu101–ofu101.
   PubMedGoogle Scholar
• Bolotin S, Hughes SL, Gul N, et al. What is the evidence to support a correlate of protection for measles? A systematic review. J Infect Dis. 2019. DOI:10.1093/infdis/jiz380.
   PubMed Web of Science ®Google Scholar
• Baldo V, Floreani A, Vecchio LD, et al. Occupational risk of blood-borne viruses in healthcare workers: a 5-year surveillance program. Infect Control Hosp Epidemiol. 2002;23(6):325–327.
   PubMed Web of Science ®Google Scholar
• Tokars JI, Marcus R, Culver DH, et al. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann Intern Med. 1993;118(12):913–919.
   PubMed Web of Science ®Google Scholar
• Venier AG, Vincent A, L’Hériteau F, et al. Surveillance of occupational blood and body fluid exposures among French healthcare workers in 2004. Infect Control Hosp Epidemiol. 2007;28(10):1196–1201.
   PubMed Web of Science ®Google Scholar
• Waaijenborg S, Hahné SJ, Mollema L, et al. Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis. 2013;208(1):10–16.
   PubMed Web of Science ®Google Scholar
• Borrow R, Andrews N, Findlow H, et al. Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine. Clin Vaccin Immunol. 2010;17(1):154–159.
   PubMed Web of Science ®Google Scholar
• Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007;357(19):1903–1915.
   PubMed Web of Science ®Google Scholar
• Fraser C, Tomassini JE, Xi L, et al. Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine. Vaccine. 2007 May 22;25(21):4324–4333.
   PubMed Web of Science ®Google Scholar
• Scheifele DW, Ochnio JJ. The immunological basis for immunization series. Module 2: diphtheria. Geneva, Switzerland: World Health Organization; 2009.
   Google Scholar
• Borrow R, Balmer P, Roper MH, et al. Immunological basis for immunization: module 3: tetanus (update 2006). Geneva, Switzerland: World Health Organization; 2007.
   Google Scholar
• Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis. 1990;161(3):480–486.
   PubMed Web of Science ®Google Scholar
• Siber GR, Chang I, Baker S, et al. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine. 2007;25(19):3816–3826.
   PubMed Web of Science ®Google Scholar
• Andrews NJ, Waight PA, Burbidge P, et al. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis. 2014;14(9):839–846.
   Google Scholar
• Käyhty R, Peltola H, Karanko V, et al. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis. 1983;147(6):1100.
   PubMed Web of Science ®Google Scholar
• Andrews N, Borrow R, Miller E. Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England. Clin Diagn Lab Immunol. 2003;10(5):780–786.
   PubMedGoogle Scholar
• Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: reevaluation of protective titers. J Infect Dis. 1990;162(5):1036–1042.
   PubMed Web of Science ®Google Scholar
• Woudenberg T, van Binnendijk R, Veldhuijzen I, et al. Additional evidence on serological correlates of protection against measles: an observational cohort study among once vaccinated children exposed to measles. Vaccines. 2019;7(4):158.
   Google Scholar
• Andrews N, Pebody R, Berbers G, et al. The European sero-epidemiology network: standardizing the enzyme immunoassay results for measles, mumps and rubella. Epidemiol Infect Immunity. 2000;125(1):127–143.
   PubMed Web of Science ®Google Scholar
• Kaaijk P, Wijmenga-Monsuur AJ, van Houten MA, et al. A third dose of measles-mumps-rubella vaccine to improve immunity against mumps in young adults. J Infect Dis. 2019. DOI:10.1093/infdis/jiz188
   Web of Science ®Google Scholar
• van Lier A, Smits G, Mollema L, et al. Varicella zoster virus infection occurs at a relatively young age in The Netherlands. Vaccine. 2013;31(44):5127–5133.
   PubMed Web of Science ®Google Scholar
• Robertson S. The immunological basis for immunization series module 6: poliomyelitis. Geneva, Switzerland: World Health Organization; 1993.
   Google Scholar
• The immunological basis for immunization series module 22: hepatitis B. World Health Organization; 2012.
   Google Scholar
• The immunological basis for immunization series: module 18 - hepatitis A. World Health Organization; 2019.
   Google Scholar
• Sato H, Albrecht P, Reynolds DW, et al. Transfer of measles, mumps, and rubella antibodies from mother to infant: its effect on measles, mumps, and rubella immunization. Am J Dis Children. 1979;133(12):1240–1243.
   PubMedGoogle Scholar
• Bolotin S, Lim G, Dang V, et al. The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009–2014. Plos One. 2017;12(8):e0181172.
   PubMed Web of Science ®Google Scholar
• Griffiths PD, Stagno S, Pass RF, et al. Infection with cytomegalovirus during pregnancy: specific IgM antibodies as a marker of recent primary infection. J Infect Dis. 1982;145(5):647–653.
   PubMed Web of Science ®Google Scholar
• Haan L, Verweij WR, Holtrop M, et al. Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity. Vaccine. 2001 Apr 06;19(20):2898–2907.
   PubMed Web of Science ®Google Scholar
• Moldoveanu Z, Clements ML, Prince SJ, et al. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine. 1995 Jan 01;13(11):1006–1012.
   PubMed Web of Science ®Google Scholar
• van Splunter M, van Hoffen E, Floris-Vollenbroek EG, et al. Oral cholera vaccination promotes homing of IgA+ memory B cells to the large intestine and the respiratory tract. Mucosal Immunol. 2018 Feb 21;11(4):1254–1264.
   PubMed Web of Science ®Google Scholar
• Crotty S, Felgner P, Davies H, et al. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol. 2003;171(10):4969–4973.
   PubMed Web of Science ®Google Scholar
• Le T, Cherry JD, Chang S-J, et al. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT study. J Infect Dis. 2004;190(3):535–544.
   PubMed Web of Science ®Google Scholar
• Antia A, Ahmed H, Handel A, et al. Heterogeneity and longevity of antibody memory to viruses and vaccines. PLoS Biol. 2018;16(8):e2006601.
   PubMed Web of Science ®Google Scholar
• Dixon FJ, Talmage DW, Maurer PH, et al. The half-life of homologous gamma globulin (antibody) in several species. J Exp Med. 1952;96(4):313–318.
   Web of Science ®Google Scholar
• Jahnmatz M, Kesa G, Netterlid E, et al. Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses. J Immunol Methods. 2013;391(1–2):50–59.
   PubMed Web of Science ®Google Scholar
• Schreiber JR, Barrus V, Cates KL, et al. Functional characterization of Human IgG, IgM, and IgA antibody directed to the capsule of Haemophilus influenzae type b. J Infect Dis. 1986;153(1):8–16.
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Kaur R, Casey JR, et al. Antibody response to Haemophilus influenzae outer membrane protein D, P6, and OMP26 after nasopharyngeal colonization and acute otitis media in children. Vaccine. 2010;28(44):7184–7192.
   PubMed Web of Science ®Google Scholar
• Davidkin I, Jokinen S, Broman M, et al. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis. 2008;197(7):950–956.
   PubMed Web of Science ®Google Scholar
• Glikmann G, Mordhorst C-H. Secretory and serum immunoglobulin class-specific antibodies to mumps virus after a natural mumps infection. Serodiag Immun Infect Dis. 1987 Aug 01;1(4):275–285.
   Google Scholar
• Hanson LA, Carlsson B, Jalil F, et al. Different secretory IgA antibody responses after immunization with inactivated and live poliovirus vaccines. Clinl Infect Dis. 1984;6(Supplement_2):S356–S360.
   Google Scholar
• Chandra RK. Reduced secretory antibody response to live attenuated measles and poliovirus vaccines in malnourished children. BMJ. 1975;2(5971):583–585.
   Google Scholar
• de Voer RM, Schepp RM, Versteegh FGA, et al. Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay. Clin Vaccin Immunol. 2009 March 1;16(3):433–436.
   PubMedGoogle Scholar
• Scherpenisse M, Schepp RM, Mollers M, et al. Comparison of different assays to assess human papillomavirus (HPV) type 16- and 18-specific antibodies after HPV infection and vaccination. Clin Vaccin Immunol. 2013 August 1;20(8):1329–1332.
   PubMedGoogle Scholar
• Smits GP, van Gageldonk PG, Schouls LM, et al. Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus. Clin Vaccin Immunol. 2012;19(3):396–400.
   PubMed Web of Science ®Google Scholar
• Thomas MG, Redhead K, Lambert HP. Human serum antibody responses to bordetella pertussis infection and pertussis vaccination. J Infect Dis. 1989;159(2):211–218.
   PubMed Web of Science ®Google Scholar
• Johnson PR, Feldman S, Thompson JM, et al. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and Inactivated vaccine. J Infect Dis. 1986;154(1):121–127.
   PubMed Web of Science ®Google Scholar
• Wendelboe AM, Van Rie A, Salmaso S, et al. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24(5):S58–S61.
   PubMedGoogle Scholar
• Scherpenisse M, Schepp RM, Mollers M, et al. Characteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclasses. Plos One. 2013;8(9):e74797.
   PubMed Web of Science ®Google Scholar
• Grangeot-Keros L, Mayaux MJ, Lebon P, et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis. 1997;175(4):944–946.
   PubMed Web of Science ®Google Scholar
• Li Z-N, Lin S-C, Carney PJ, et al. IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States. J Clin Vac Immunol. 2014;21(8):1054–1060.
   Google Scholar
• van der Heiden M, van Ravenhorst MB, Bogaard M, et al. Lower antibody functionality in middle-aged adults compared to adolescents after primary meningococcal vaccination: role of IgM. Exp Gerontol. 2018 May 01;105:101–108.
   PubMed Web of Science ®Google Scholar
• Wilson R, Cohen JM, Reglinski M, et al., Naturally acquired human immunity to pneumococcus is dependent on antibody to protein antigens. PLoS Pathog. 2017;13(1):e1006137.
   PubMed Web of Science ®Google Scholar
• Horton RE, Stuart J, Christensen H, et al. Influence of age and carriage status on salivary IgA to Neisseria meningitidis. Epidemiol Infect. 2005;133(5):883–889.
   PubMed Web of Science ®Google Scholar
• Shepard CW, Simard EP, Finelli L, et al. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006;28(1):112–125.
   PubMedGoogle Scholar
• Hird TR, Grassly NC. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog. 2012;8(4):e1002599.
   PubMed Web of Science ®Google Scholar
• Wright PF, Wieland-Alter W, Ilyushina NA, et al. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination. J Infect Dis. 2014;209(10):1628–1634.
   PubMed Web of Science ®Google Scholar
• Kew O, Morris-Glasgow V, Landaverde M, et al. Outbreak of poliomyelitis in hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science. 2002;296(5566):356–359.
   Google Scholar
• Andrews NJ, Waight PA, George RC, et al. Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and wales. Vaccine. 2012 Nov 06;30(48):6802–6808.
   PubMed Web of Science ®Google Scholar
• Eskola J, Käyhty H, Takala AK, et al. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive haemophilus influenzae type b disease. N Engl J Med. 1990;323(20):1381–1387.
   PubMed Web of Science ®Google Scholar
• Korkeila M, Lehtonen H, Åhman H, et al. Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid. Vaccine. 2000 Jan 21;18(13):1218–1226.
   PubMed Web of Science ®Google Scholar
• van Ravenhorst MB, den Hartog G, van der Klis FRM, et al. Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine. Plos One. 2018;13(4):e0191261.
   PubMed Web of Science ®Google Scholar
• Macpherson AJ, Gatto D, Sainsbury E, et al. A Primitive T Cell-Independent Mechanism of Intestinal Mucosal IgA Responses to Commensal Bacteria. Science. 2000;288(5474):2222–2226.
   PubMed Web of Science ®Google Scholar
• McDermott MR, Bienenstock J. Evidence for a common mucosal immunologic system. I migration of B immunoblasts into intestinal, respiratory, and genital tissues. J Immunol. 1979;122(5):1892–1898.
   Google Scholar
• Moor K, Diard M, Sellin ME, et al. High-avidity IgA protects the intestine by enchaining growing bacteria. Nature. 2017 Apr 12;544(7651):498. online.
   PubMed Web of Science ®Google Scholar
• Newcomb RW, Ishizaka K, DeVald BL. Human IgG and IgA diphtheria antitoxins in serum, nasal fluids and saliva. J Immunol. 1969;103(2):215–224.
   PubMed Web of Science ®Google Scholar
• Loman S, Radl J, Jansen HM, et al. Vectorial transcytosis of dimeric IgA by the Calu-3 human lung epithelial cell line: upregulation by IFN-gamma. Am J Physiol Lung Cell Mol Physiol. 1997;272(5):L951–L958.
   PubMed Web of Science ®Google Scholar
• Kaetzel CS, Mestecky J, Johansen F-E. Two cells, one antibody: the discovery of the cellular origins and transport of secretory IgA [10.4049/jimmunol.1700025]. J Immunol. 2017;198(5):1765.
   PubMed Web of Science ®Google Scholar
• Stoof SP, van der Klis FR, van Rooijen DM, et al. Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming: systemically induced local immunity and saliva as potential surveillance tool. Vaccine. 2015;33(32):3933–3939.
   PubMed Web of Science ®Google Scholar
• Stoof SP, Buisman A-M, van Rooijen DM, et al. Different dynamics for IgG and IgA memory B cells in adolescents following a meningococcal serogroup C tetanus toxoid conjugate booster vaccination nine years after priming: a role for priming age? Plos One. 2015;10(10):e0138665.
   PubMed Web of Science ®Google Scholar
• Miller E, Andrews NJ, Waight PA, et al. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and wales: an observational cohort study. Lancet Infect Dis. 2011 Oct 01;11(10):760–768.
   PubMed Web of Science ®Google Scholar
• Maiden MCJ, Stuart JM. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet. 2002 May 25;359(9320):1829–1830.
   PubMed Web of Science ®Google Scholar
• Mitsi E, Roche AM, Reine J, et al. Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage. Mucosal Immunol. 2016 Aug 31;10:385–394. online.
   PubMed Web of Science ®Google Scholar
• Takai T. Roles of Fc receptors in autoimmunity [Review #rticle]. Nat Rev Immunol. 2002 Aug 01;2(8):580. online.
   PubMed Web of Science ®Google Scholar
• Bemark M, Hazanov H, Strömberg A, et al. Limited clonal relatedness between gut IgA plasma cells and memory B cells after oral immunization [Article]. Nat Commun. 2016 Sep 06;7(1):12698. online.
   PubMedGoogle Scholar
• Bruhns P, Iannascoli B, England P, et al. Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses. Blood. 2009;113(16):3716–3725.
   PubMed Web of Science ®Google Scholar
• Stapleton NM, Andersen JT, Stemerding AM, et al. Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nat Commun. 2011;2:599.
   Google Scholar
• El Mubarak HS, Ibrahim SA, Vos HW, et al. Measles virus protein-specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infection. J Med Virol. 2004;72(2):290–298.
   Google Scholar
• de Voer RM, van der Klis FRM, Engels CWAM, et al. Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides. Clin Vaccin Immunol. 2008 August 1;15(8):1188–1193.
   PubMedGoogle Scholar
• Arita M, Iwai M, Wakita T, et al. Development of a poliovirus neutralization test with poliovirus pseudovirus for measurement of neutralizing antibody titer in human serum. Clin Vaccin Immunol. 2011 November 1;18(11):1889–1894.
   PubMedGoogle Scholar
• Henckaerts I, Durant N, De Grave D, et al. Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children. Vaccine. 2007;25(13):2518–2527.
   PubMed Web of Science ®Google Scholar
• Sowers SB, Rota JS, Hickman CJ, et al. High concentrations of measles neutralizing antibodies and high-avidity measles IgG accurately identify measles reinfection cases. Clin vaccin immunol. 2016;23(8):707–716.
   PubMed Web of Science ®Google Scholar
• Hahne SJ, Nic Lochlainn LM, van Burgel ND, et al. Measles outbreak among previously immunized healthcare workers, the Netherlands, 2014. J Infect Dis. 2016 Dec 15;214(12):1980–1986.
   PubMed Web of Science ®Google Scholar
• Borrow R, Balmer P, Miller E. Meningococcal surrogates of protection—serum bactericidal antibody activity. Vaccine. 2005;23(17–18):2222–2227.
   PubMed Web of Science ®Google Scholar
• Schlesinger Y, Granoff DM, Murphy TV, et al. Avidity and bactericidal activity of antibody elicited by different haemophilus influenzae type b conjugate vaccines. JAMA. 1992;267(11):1489–1494.
   PubMed Web of Science ®Google Scholar
• Brown EP, Weiner JA, Lin S, et al. Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1/SIV. J Immunol Methods. 2018 Apr 01;455:24–33.
   PubMed Web of Science ®Google Scholar
• Vidarsson G, Dekkers G, Rispens T. IgG Subclasses and allotypes: from structure to effector functions [Review]. Front Immunol. 2014 October 20;5(520). DOI:10.3389/fimmu.2014.00520
   PubMedGoogle Scholar
• Dekkers G, Treffers L, Plomp R, et al. Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor- and complement-mediated-effector activities. Front Immunol. 2017;8:877.
   PubMed Web of Science ®Google Scholar
• Brown EP, Dowell KG, Boesch AW, et al. Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles. J Immunol Methods. 2017 Apr 01;443:33–44.
   PubMed Web of Science ®Google Scholar
• Christensen D, Mortensen R, Rosenkrands I, et al. Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses [Article]. Mucosal Immunol. 2017 Jan;10(1):260–270 print.
   PubMed Web of Science ®Google Scholar
• Pinna D, Corti D, Jarrossay D, et al. Clonal dissection of the human memory B-cell repertoire following infection and vaccination. Eur J Immunol. 2009 May;39(5):1260–1270.
   PubMed Web of Science ®Google Scholar
• Omer SB, Salmon DA, Orenstein WA, et al. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med. 2009;360(19):1981–1988.
   PubMed Web of Science ®Google Scholar
• Gust DA, Darling N, Kennedy A, et al. Parents with doubts about vaccines: which vaccines and reasons why. Pediatrics. 2008;122(4):718–725.
   PubMed Web of Science ®Google Scholar
• David S, Vermeer-de Bondt PE, van der Maas NAT. Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands. Vaccine. 2008 Oct 29;26(46):5883–5887.
   PubMed Web of Science ®Google Scholar
• Arvin A. Aging, immunity, and the varicella–zoster virus. N Engl J Med. 2005;352(22):2266–2267.
   PubMed Web of Science ®Google Scholar
• Wang C, Liu Y, Xu LT, et al. Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires. J Immunol. 2013 Jan 15;192(2):603–611.
   Web of Science ®Google Scholar
• Lucidarme J, Scott K, Ure R, et al. An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, july to august 2015 [Research]. Eurosurveillance. 2016 November 10;21(15). DOI:10.2807/1560-7917.ES.2016.21.45.30395.
   Google Scholar
• Elberse KEM, van der Heide HGJ, Witteveen S, et al. Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine. Vaccine. 2012 Dec 14;30(52):7644–7651.
   PubMed Web of Science ®Google Scholar
• Barkoff A-M, Mertsola J, Pierard D, et al. Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015. Euro Surveill. 2019;24(7):1700832.
   Google Scholar
• Bodilis H, Guiso N. Virulence of pertactin-negative bordetella pertussis isolates from infants, France. Emerg Infect Dis. 2013;19(3):471–474.
   PubMed Web of Science ®Google Scholar
• Smith DJ, Lapedes AS, de Jong JC, et al. Mapping the antigenic and genetic evolution of influenza virus. Science. 2004;305(5682):371–376.
   PubMed Web of Science ®Google Scholar
• Nachbagauer R, Choi A, Hirsh A, et al. Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins [Research]. Nat Immunol. 2017 Feb 13;18(4):464–473. online;advance online publication.
   PubMed Web of Science ®Google Scholar
• van Beek J, Veenhoven RH, Bruin JP, et al. Influenza-like illness incidence is not reduced by influenza vaccination in a cohort of older adults, despite effectively reducing laboratory-confirmed influenza virus infections. J Infect Dis. 2017;216(4):415–424.
   PubMed Web of Science ®Google Scholar
• Homan EJ, Bremel RD. Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes?: An immunoinformatic analysis. Hum Vaccin Immunother. 2014;10(2):290–300.
   PubMed Web of Science ®Google Scholar
• May M, Rieder CA, Rowe RJ. Emergent lineages of mumps virus suggest the need for a polyvalent vaccine. Inter J Infect Dis. 2018 Jan 01;66:1–4.
   PubMed Web of Science ®Google Scholar
• Epstein SL, Tumpey TM, Misplon JA, et al. DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. Emerg Infect Dis. 2002;8(8):796.
   PubMed Web of Science ®Google Scholar
• Pizza M, Scarlato V, Masignani V, et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science. 2000;287(5459):1816–1820.
   PubMed Web of Science ®Google Scholar
• Hessell AJ, Poignard P, Hunter M, et al. Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques. Nat Med. 2009;15(8):951.
   PubMed Web of Science ®Google Scholar
• van der Heiden M, van Zelm MC, Bartol SJ, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6(1):26892.
   PubMedGoogle Scholar
• Tcherniaeva I, den Hartog G, Berbers G, et al. The development of a bead-based multiplex immunoassay for the detection of IgG antibodies to CMV and EBV. J Immunol Methods. 2018;462:1–8.
   PubMed Web of Science ®Google Scholar
• Meek B, Ekström N, Kantsø B, et al. Multilaboratory comparison of pneumococcal multiplex immunoassays used in immunosurveillance of streptococcus pneumoniae across Europe. mSphere. 2019;4(6):e00455–19.
   Google Scholar